Merck & Co., Inc. (MRK)
145.27
-1.97
(-1.34%)
USD |
NYSE |
Oct 23, 16:00
145.35
+0.08
(+0.06%)
Pre-Market: 20:00
Merck Price to Book Value : 8.552 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 8.552 |
| October 22, 2026 | 8.668 |
| October 21, 2026 | 8.824 |
| October 20, 2026 | 8.731 |
| October 19, 2026 | 8.456 |
| October 16, 2026 | 8.592 |
| October 15, 2026 | 8.548 |
| October 14, 2026 | 8.676 |
| October 13, 2026 | 8.358 |
| October 12, 2026 | 8.563 |
| October 09, 2026 | 8.572 |
| October 08, 2026 | 8.382 |
| October 07, 2026 | 8.406 |
| October 06, 2026 | 8.356 |
| October 05, 2026 | 8.215 |
| October 02, 2026 | 8.495 |
| October 01, 2026 | 8.466 |
| September 30, 2026 | 8.555 |
| September 29, 2026 | 8.788 |
| September 28, 2026 | 8.754 |
| September 25, 2026 | 8.759 |
| September 24, 2026 | 8.712 |
| September 23, 2026 | 8.718 |
| September 22, 2026 | 8.884 |
| September 21, 2026 | 8.801 |
| Date | Value |
|---|---|
| September 18, 2026 | 8.646 |
| September 17, 2026 | 8.663 |
| September 16, 2026 | 8.531 |
| September 15, 2026 | 8.465 |
| September 14, 2026 | 8.528 |
| September 11, 2026 | 8.473 |
| September 10, 2026 | 8.519 |
| September 09, 2026 | 8.685 |
| September 08, 2026 | 8.74 |
| September 04, 2026 | 8.850 |
| September 03, 2026 | 8.968 |
| September 02, 2026 | 8.927 |
| September 01, 2026 | 8.822 |
| August 31, 2026 | 8.699 |
| August 28, 2026 | 8.734 |
| August 27, 2026 | 8.804 |
| August 26, 2026 | 9.013 |
| August 25, 2026 | 9.210 |
| August 24, 2026 | 8.870 |
| August 21, 2026 | 8.981 |
| August 20, 2026 | 8.771 |
| August 19, 2026 | 8.960 |
| August 18, 2026 | 7.958 |
| August 17, 2026 | 8.005 |
| August 14, 2026 | 7.997 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Johnson & Johnson | 7.789 |
| Eli Lilly & Co. | 35.39 |
| Pfizer Inc. | 2.009 |
| Bristol Myers Squibb Co. | 5.628 |
| Viatris, Inc. | 1.458 |
Price to Book Value Related Metrics
| PE Ratio | 116.11 |
| PS Ratio | 5.439 |
| Price to Free Cash Flow | 22.45 |
| Price | 145.27 |
| Earnings Yield | 0.86% |
| Market Cap | 358.62B |
| Operating PE Ratio | 28.92 |
| Normalized PE Ratio | 48.03 |